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Abstract Huntington’s disease, a major neurodegenerative disorder, involves expression and 
deposition of highly aggregation-prone proteins with a long polyglutamine (polyQ) expansion. 
However, whether these intracellular aggregations are pathological or protective still remains 
elusive. Here, we propose stimulated Raman scattering (SRS) imaging of deuterium-labeled 
glutamine to investigate native polyQ aggregations in live cells with subcellular resolution. 
Technically, enrichment of deuterated glutamine in polyQ sequence enables sensitive and 
specific SRS imaging of carbon-deuterium bonds (C-D) from the aggregates without GFP 
labeling, as typically required for fluorescence microscopy. Biologically, we first reveal that 
these aggregates become 1.8 times denser without GFP, confirming its perturbation. Second, 
with SRS quantification, we discover a two-stage aggregation formation model, in which small 
aggregates are dominated by cytosolic proteins in the first stage, but then prefer to sequester 
polyQ proteins with size growth. This suggests that small aggregates are cytotoxic while large 
aggregates play a protective role. Third, we illustrate that polyQ aggregations are not a highly 
dense solid structure by calculating their absolute protein concentrations to be around millimolar 
range. Furthermore, hyperspectral SRS (hSRS) mapping of C-D vibrations reveals spectroscopic 
features corresponding to aggregation formation. This is largely absent in label-free SRS or SRS 
imaging of other non-glutamine amino acid probes. Applying hSRS to interrogating polyQ 
aggregations by inducing heat shock responses indicates a conformational intermediate with a 
changed hydrogen-bonding network. Altogether, our quantitative SRS imaging and 
spectroscopic analysis strategy offers new structural-functional insights for the molecular role of 
polyQ aggregates.  
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Introduction  
       One hallmark of neurodegenerative disorders is the presence of protein aggregations in the 
patient brains1-4. Among which, polyglutamine (polyQ) diseases, such as Huntington’s disease 
(HD), is one main kind that usually starts with motor symptoms like chorea and followed by 
memory deficit and depressions3,4. The onset of HD has been linked to abnormal CAG 
trinucleotide repeats that encodes polyQ expansion sequence in mutant Hungtingtin (mHtt) 
proteins. While Q repeats are typically fewer than 37 in healthy human, they range from 40 to 
250 in mHtt proteins and are consistently found in the protein depositions of HD brain slices by 
immunohistology1,3. However, the molecular role of polyQ aggregations for their cytotoxicity 
remains controversial in the HD disease2,4-6. It has recently been suggested that soluble oligomers 
are cytotoxic by dynamically interacting with functional proteins and triggering apoptosis while 
aggregations are cyto-protective by sequestering toxic protein oligomers to form stable inclusion 
bodies4,7,8. In contrast, evidence also indicates that toxicity of aggregates arises from depleting 
essential functional (e.g. chaperones and transcription factors) and structural (e.g. actin) proteins 
as well as impairing cellular organelles (e.g. ribosomes and endoplasmic reticulum)9-13.  
 
       To understand their molecular roles, extensive efforts have been made to investigate the 
compositions, structures and kinetics of mHtt aggregations. Conventional biochemical assays 
and recent quantitative proteomics offer relative protein compositions from the aggregates in 
reference to the soluble pools. However, they rely on extensive post-processing such as 
aggregation purification and solubilization9,10. In vitro spectroscopic studies including IR14, UV-
resonance Raman15,16, NMR spectroscopy17 and fluorescence18,19 on model peptides provide 
crucial information. But they are typically limited to short expansion length (e.g. K2Q24K2W) 
due to the difficulty to isolate the peptides with longer Q14-19. More importantly, all these in vitro 
studies cannot recapitulate the native aggregation status in live and complex intracellular 
environment and lack fine spatial information. For live-cell studies, fluorescence imaging offers 
unprecedented spatial and temporal resolution by genetically-encoded fluorescent proteins20 or 
self-labeling tags (e.g. HaloTag)21 to the C-terminus of a well-established model mHtt exon1 
(ex1) sequence with various polyQ lengths (Fig. 1a). The aggregation-prone ex1 fragment, 
composed of 17 N-terminal amphipathic amino acids (aa), a polyQ tract followed by proline-rich 
residues at C terminus (Fig. 1a), can effectively induce pathological phenotype of HD in 
transgenic mouse model and humans4,22. Compared to mHtt ex1, however, GFP is much larger in 
size and has known tendency to oligomerize23. This could perturb the ex1 aggregation kinetics 
and conformations, hence contributing to the controversy of reported toxicity. Moreover, 
quantification and spectroscopic information of aggregates available from in vitro studies is 
largely missing in fluorescence imaging. It is therefore highly desirable to have a new modality 
that combines the advantages from both in vitro investigations and fluorescence imaging while 
overcoming their limitations.  
 
Results and Discussion 
 
       Proof-of-Principle SRS Imaging of mHtt Aggregations with Glutamine-d5 (Gln-d5) 
Labeling in Live HeLa Cells. Herein, we report a method for live-cell imaging and 
quantification of polyQ aggregates with minimum perturbation, subcellular resolution and 
spectral information by stimulated Raman scattering (SRS) microscopy of deuterium-labeled 
glutamine (Gln) (Fig. 1b, c). Labeling of aggregates is achieved through replacing regular Gln in 
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the medium with the corresponding Gln-d5 (Fig. 1c) so that cells would metabolically 
incorporate and enrich Gln-d5 into the long polyQ tail of expressed mHtt ex1 proteins (Fig. 1a). 
We first determined our SRS detection limit on Gln-d5 solution to be 3 mM (Fig. 1d, when signal 
(S)/noise (N)=1, targeting C-D vibrational peak at 2147 cm-1). This indicates that our detection 
limit for mHtt protein is down to 29 μM with a total of 103 Gln enrichment in the widely 
adopted mHtt-97Q ex1 protein (details in SI). It offers higher detection sensitivity compared to 
SRS imaging of alkyne tags, which is limited to about 200 μM 24. In cells, however, the detection 
limit is set by aggregation-signal to cellular-background ratio (Agg/Cell) because newly 
synthesized proteome also incorporates Gln serving as background, but with a much lower 
abundance (4.2 %)25. The estimated detectability for mHtt-97Q ex1 is 86 μM when Agg/Cell 
ratio equals to 1 (details in SI). At this concentration, the SRS image quality set by S/N is high. 
We note that the intracellular free amino acid Gln pool is about 8 mM26, which slightly lowers 
Agg/Cell limited detectability. To minimize this additional background source, we replaced 
medium with buffer before imaging.  
 
       We next validated our SRS imaging by transfecting cells with mHtt-97Q-GFP plasmid (Fig. 
1a and S1) and culturing them in Gln-d5 labeling medium. Fig. 2a confirms that SRS imaging of 
the aggregates (Fig. 2a, 2167 cm-1) in live HeLa cells co-localizes well with that by confocal 
fluorescence from GFP. Clear off-resonance image demonstrates high SRS imaging quality (Fig. 
2a, 2035 cm-1). The C-D peak-shape change by shifting the highest peak from 2147 cm-1 in 
solution to 2167 cm-1 after Gln-d5 being incorporated into cellular proteins should be due to 
varied microenvironment (Fig. S2). In contrast, label-free SRS images at CH3 (2940 cm
-1) and 
amide I (1664 cm-1), typically adopted for imaging total proteins27, show much decreased 
detection specificity, particularly for smaller-size aggregations (Fig 2b and 2d, indistinguishable 
from the nucleoli, arrow indicated). Moreover, the average Agg/Cell ratio of high-contrast C-D 
images from Gln-d5 decreases significantly if replaced with non-enriched Leucine-d10 (Leu-d10) 
labeling (Fig. 2c and 2d), confirming that the high imaging specificity comes from the 
enrichment of Gln-d5 in polyQ tract.  
 
       SRS Imaging and Quantification of Native mHtt-97Q Aggregates without GFP 
Labeling. After demonstrating the feasibility and the specificity of Gln-d5 labeling for SRS 
imaging of mHtt-97Q-GFP aggregates, we aim to image native mHtt-97Q proteins without GFP 
(Fig. 3a). The mHtt-97Q ex1 has only 152 aa, while GFP is 238 aa long, about twice in size. We 
observed bright aggregates by SRS imaging at the same C-D frequency (Fig. 3b, CD on and off). 
Interestingly, these aggregates (Fig. 3b, 2167 cm-1) are significantly brighter compared to those 
with GFP (Fig. 2a, 2167 cm-1). We reason that since the C-D intensity should remain about the 
same when chopping off GFP sequence, which only contains 8 Gln, the intensity increase is from 
the formation of denser aggregates. Similar phenomenon was recently reported by Cryo-ET11. To 
further confirm this claim, amide I image (Fig. 3b, 1664 cm-1) shows similar intensity to that 
with GFP (Fig. S3, 1664 cm-1), because the increase of mHtt-97Q density makes up for the loss 
of amide I intensity from GFP. Furthermore, aggregates of mHtt-97Q in CH3 channel become 
barely distinguishable from cellular background (Fig. 3b, 2940 cm-1) because previous CH3 
signals for aggregates largely come from the GFP sequence (Fig. S1).  
 
       Thanks to linear concentration dependence and the multi-channel SRS ratiometric analysis, 
we quantitatively examined the compositional changes between mHtt-97Q and mHtt-97Q-GFP 
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aggregates (Fig. 3c and 3d). First, Agg/Cell ratio from SRS images of Gln-d5 labeled mHtt-97Q 
aggregates is 1.8 times higher in C-D channel while marginally decreased in CH3 than that of 
mHtt-97Q-GFP (Fig. 3c). These changes mostly originate from 1.8-time denser mHtt 
aggregations, since cytosolic background should not be influenced by the change of plasmid 
sequence. Second, we analyzed CH/C-D ratios, representing the ratios between non-Htt proteins 
(mostly containing non-Q aa) to mHtt proteins (enriched with C-D by Gln-d5 labeling) within 
the same aggregates (Fig. 3d). Surprisingly, the average is still 5.75 even for mHtt-97Q 
aggregates (Fig. 3d). Based on the sequence (Fig. S1), it should be only around 0.5 (49 non-Q aa 
/ 103 Q) if aggregations were formed primarily by mHtt-97Q proteins, considering our labeling 
efficiency by Gln-d5 is close to 100% (i.e. de novo glutamine synthesis is about zero, Fig. S4 and 
S5) and C-D Raman cross section is the same as that of CH (confirmed by SRS measurement on 
pure DMSO-d6 and DMSO). Similarly, the CH/CD ratios should have decreased 5 times (from 
289 non-Q aa / 112 Q to 49 non-Q aa / 103 Q). Instead, we only observed 1.5 times decrease. 
Altogether, this implies that the aggregations contain a rather high percentage of non-mHtt 
proteins (we calculated it to be around 54% in molar percentage, details in SI). Sequestration of 
cellular functional and structural proteins has been suggested to be one underlying mechanism of 
cytotoxicity by aggregation formations in HD disease9-13. Our method hence offers a quantitative 
measurement that corroborate with this mechanism. 
 
       Quantifications for the Dependence of Protein Compositions on Aggregation Sizes 
Reveal A Two-Stage Aggregation Sequestration. To further understand the molecular 
cytotoxicity of polyQ aggregations, we then interrogated the dependence of proteins 
compositions (i.e. CH/CD ratios) on aggregation sizes (Fig. 4a). Intriguingly, we observed a 
negative correlation, demonstrating that the percentage of sequestered mHtt proteins increases as 
the aggregations grow. By categorizing these aggregations into small (<10 µm2) and large (>10 
µm2) groups, student t-tests confirmed the significance for the measured CH/CD ratio differences 
(Fig. 4b). As a comparison, such distinctive correlation is absent with Leu-d10 labeling (Fig. 4c-
d), underscoring the necessity of specific labeling. Our observations suggest a two-stage 
sequestration model during mHtt aggregation formation and growth. At the initial stage, the 
formed small aggregations preferentially sequester non-mHtt cytosolic proteins likely functional 
chaperones, ribonucleoproteins and structural proteins9-13, hence are more cytotoxic by depleting 
them. As the aggregates grow, they transit into a second-stage that would absorb more mHtt 
proteins. This indicates that large inclusion bodies may indeed play a protective role to clear 
toxic disease proteins as a cellular rescue mechanism4,7,8. Our two-stage model therefore offers a 
new insight that polyQ aggregations can be both cytotoxic (for small aggregates) and protective 
(for large aggregates), and the difference depends on sizes. 
 
       Inspired by our quantitative analysis, we set out to calculate the absolute concentrations and 
compositional percentages for mHtt and non-mHtt proteins from small to large aggregates in live 
cells. This would be highly challenging for existing methods, such as fluorescence imaging, 
because dense structures lead to self-absorption and fluorescence quenching of fluorophores, 
making it unreliable for quantifying aggregates. In addition, fluorescent proteins can only label 
known protein targets. Based on our concentration curve (Fig. 1d), we first determined that the 
mHtt concentration in a representative small aggregate (Fig. 4a, green dot, 6.7 μm2) is between 
1.1 mM (when all sequestered cytosolic non-mHtt proteins are newly synthesized and hence 
incorporated with Gln-d5 contributing to the C-D signal) and 2.1 mM (assuming all sequestered 
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cytosolic non-mHtt proteins are pre-existing proteins) (Fig. 4e, all details in SI and Table S1). 
Similarly, a large aggregate (Fig. 4a, red dot, 19.1 μm2) has mHtt concentrations between 4.2 and 
5.1 mM (Fig. 4f). The concentrations continue to increase with bigger ones (Fig. 4a, magenta dot, 
Table S1, 5.6 - 6.4 mM). Surprisingly, the concentrations of non-mHtt proteins remain almost 
the same from small to large aggregations (from 4.6 (Fig. 4a, green dot) to 4.7 (Fig. 4a, red dot)) 
and then gradually decrease with further size increase (Fig. 4a, magenta dot, 4.2 mM). On 
average, non-mHtt proteins account for 74.5% molar percentage in small aggregates to 50% in 
large aggregates and to 40.8% in even larger ones (Table S1). Based on these data, polyQ 
aggregates have total protein concentrations of 5-10 mM and are less dense than we typically 
expected as solid inclusion bodies. To the best of our knowledge, this is the first that specific 
protein concentrations and percentages could be given for aggregates of different sizes in live 
cells.     
 
       Understand the Structures of mHtt Aggregates by Hyperspectral SRS (hSRS) Imaging. 
One key advantage for in vitro spectroscopic analysis over live-cell fluorescence imaging is the 
structural and conformational information of the aggregates14-19.  For instance, multiple reports 
suggested beta-sheet rich structures in mHtt aggregations. However, there is still no 
consensus15,18. We therefore adopted hSRS to analyze mHtt-97Q aggregates in live cells. We 
started with Amide I band since its Raman vibration was well documented to probe protein 
secondary structures in vibrational spectroscopy16. A recent report by label-free hSRS imaging of 
Amide I on amyloid plaques in brain tissues revealed a clear 12 cm-1 blue shift (resolvable by our 
spectral resolution ~12 cm-1), corresponding to cross-beta sheet structures28. Nonetheless, we 
observed no such spectroscopic difference from Amide I between mHtt aggregates and cellular 
background (Fig. 5a, 1664 cm-1, blue vs red), suggesting that beta-sheet rich structures might be 
absent in these aggregates. Note that we detected a spectral distortion upon chemical fixation 
(Fig. 5a, from 1600 to 1640 cm-1, green vs blue and magenta vs red), similarly to that suggested 
before29, highlighting the importance of performing analysis on live samples. 
 
       We next asked whether hSRS analysis on C-D spectral region could offer insightful 
structural information since Gln-d5 labeling is more specific on mHtt-97Q proteins than Amide I, 
which is general to all aa. Interestingly, we observed a clear dip around 2146 cm-1 for 
aggregations compared to that from cellular background (Fig. 5b), implying a structural 
difference between aggregated and cytosolic proteins. To understand such spectral changes, we 
compared C-D aggregation spectra (Fig. 5c, green) to those of Gln-d5 solids (purple) and 
solutions (red). The C-D spectra after Gln-d5 being incorporated into cellular proteins show a 
combinational feature of solution and solid environment. Our previously observed shift of 
primary peak from 2147 cm-1 of Gln-d5 solutions to 2167 cm
-1 for mHtt aggregations (Fig. S2) 
could also be attributed to the formation toward a solid-state structure, consistent with the major 
peak position of Gln-d5 solids (Fig. 5c). Our fitting results indicate that the 2146 cm
-1 dip is 
resulted from the narrowing and slight red shift of the shoulder peak at 2130 cm-1 (Fig. S6), 
likely due to the formation of a more ordered structure upon aggregation. It also implies that the 
shoulder peak may serve as a sensitive indicator for the microenvironment of mHtt aggregates. 
In addition to the amide I and C-D, we also evaluated CH vibrations. CH3 peaks (2940 cm
-1) 
have no discernable spectral information, since they mostly come sequestered non-mHtt proteins 
(Fig. 5d). The spectra of aggregates are almost identical to that of nucleoli, enriched with 
proteins and rRNA and the lower shoulder at around 2850 cm-1 compared to that from cell 
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background is due to CH2 vibration from cytosolic lipids. It again emphasizes the importance of 
specific C-D labeling for studying mHtt aggregates.  
 
       Investigating the Structural Changes of mHtt Aggregates by Inducing Heat Shock 
Protein (HSP) Responses. Now that we have established our technique is effective in imaging 
and analyzing the structures of native aggregates, we then applied it to understanding molecular 
interactions between polyQ aggregates and HSPs, key chaperones for protein folding and 
inhibiting protein aggregations. This may offer fundamental insights toward therapeutic 
development for HD disease6. Geldanamycin (GA) is a naturally occurring antitumor drug that 
has been shown to be active in inhibiting or solubilizing the formation of polyQ aggregations by 
triggering a heat shock response of HSP40 and 70 in mammalian cells30. We first confirmed its 
function that the number of large aggregates decreases with the treatment of increased GA 
concentrations (Fig. S7). We next resorted to C-D hSRS on the native mHtt-97Q aggregates 
without GFP. Interestingly, in GA treated samples, we discovered a subset of aggregates with 
reduced size and intensity that consistently present a varied spectral feature with a lowered 
shoulder peak at 2132 cm-1 compared to larger-size aggregates (Figs. S8a and S8b). Inspired by 
this spectroscopic observation, we came back to mHtt-97Q-GFP and adopted a correlative 
fluorescence and hSRS to understand this phenomenon (Fig. 6a). We found that such aggregates, 
when exhibiting the same SRS spectral feature as found for the mHtt-97Q subset (Fig. 6b and 
S8c), always co-exist with surrounding diffusive mHtt protein pools (Fig. 6a, Fluorescence). 
Recently, a liquid-to-solid phase transition is reported for the mHtt-97Q-GFP proteins upon 
aggregation formation31. We speculated whether such shoulder peak decrease is caused by a 
reverse phase conversion from solid mHtt aggregates toward surrounding liquid pool with up-
regulation of HSP40/70. However, the Fluorescence Loss In Photobleaching (FLIP) experiments 
on the surrounding fluorescent pool did not reveal any fluorescence exchange between the 
cytosolic and aggregated mHtt proteins (Fig. S8), ruling out our phase-transition hypothesis.  
 
       Since C-D vibration is also sensitive to microenvironment, similar to that from CH32, we 
speculated such a decrease at 2132 cm-1 shoulder peak corresponds to a change of secondary 
structures when interacting with Hsp40/70 proteins, as suggested by previous in vitro EM 
experiments33. To test this, we emerged cells containing mHtt-97Q-GFP aggregates without GA 
treatment in solvents with descending hydrogen-bonding capacity (Fig. 6c, from DPBS buffer 
(green), to MeOH (yellow) and DMSO (blue)). The 2132 cm-1 shoulder increases accordingly 
(Fig. 6c, vertical line). Quantitative fittings show a more detailed ratio increase between the 
shoulder (2130 cm-1) and the major (2169 cm-1) peaks (Fig. S10). The lowest ratio from GA 
treated subset of aggregations (Fig. S10f) hence demonstrates that its local environment has a 
more hydrated hydrogen bonding compared to regular cellular proteomes (Fig. S6d). Such hyper-
hydration might be caused by a partially folded state, a folding intermediate, by interacting with 
HSP40/70 in live cells34. 
 
Conclusion 
 
       In summary, we combined SRS microscopy with Gln-d5 labeling to achieve imaging, 
quantification and sensitive spectroscopic analysis of polyQ aggregations in HD disease. We 
demonstrated our SRS utility by imaging mHtt aggregations down to small sizes in live HeLa 
cells, quantifying the propensity and composition of mHtt aggregates, and performing hSRS 
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analysis. We revealed that the formation of aggregations become 1.8-time denser than that 
without GFP tagging, proving its possible perturbation. Our compositional quantifications of 
mHtt and non-mHtt proteins inside small to large aggregations propose a two-stage aggregation 
formation model with a surprising sequestration preference of non-mHtt proteins at the initial 
phase. This may indicate that small aggregates are toxic while large aggregates are protective. 
Additionally, we induced heat shock responses to inhibit aggregation formation and revealed a 
vibrational spectral signature, suggesting a possible change of hydrogen-bonding network for 
mHtt aggregations upon interacting with Hsp40/70.  
 
       Technically, our method manifests the following advantages. First, SRS imaging of C-D 
vibration from Gln-d5 in the desired cell-silent region (1800-2600 cm
-1) allows non-invasive 
subcellular mapping and spectral analysis of mHtt aggregates in live cells without GFP. Labeling 
on the stable side chains of Gln does not interfere with internal hydrogen-bond network, which is 
between NH2 and amide and is essential for the secondary structure of mHtt aggregates. Second, 
based on the mHtt ex1 sequence (Figs. 1a and S1), Gln is an ideal labeling target because its 
enrichment in the extended polyQ region provides both high mHtt-labeling specificity and 
imaging sensitivity. In mHtt-97Q ex1 fragment, Gln accounts for 68% of the ex1 sequence (Fig. 
S1), while the overall natural occurrence of Gln is only about 4.2% in human proteomes25. We 
experimentally confirmed close to 100% labeling efficiency by Gln-d5. Compared to label-free 
SRS27, or SRS of 13C-Phenyalanine35 and deuterated all essential amino acids36 for imaging 
proteins, our selective Gln-d5 labeling is significantly more specific. Unlike alkyne-tagged 
unnatural amino acids, with which only one tag is introduced to one protein37, multiple Q 
labeling (e.g. 103Q for mHtt-97Q ex1) by Gln-d5 offers much higher sensitivity and less 
manipulation and invasiveness. Third, compared to Coherent anti-Stokes Raman scattering 
(CARS)38, another nonlinear microscopy technique, SRS offers high-fidelity Raman spectra (Fig. 
1b) and linear concentration dependence without non-resonance background. Owing to the high-
fidelity linear concentration dependence, we were able to quantify aggregation compositions in 
situ from live cells. Fourth, hSRS on the C-D spectral window is suited for investigating the 
microenvironment of mHtt aggregations.  
 
       Our method is generally applicable to other polyQ diseases including spinocerebellar ataxia 
and spinobulbar muscular atrophy39 and other poly-aa diseases involves low complexity 
sequences, such as with poly-GA, poly-GR, poly-GP, poly-PR, and poly-PA40,41 aggregates 
recently reported in ALS/FTD patient brain by selective deuteration of corresponding aa. In 
addition, since Gln can transport across blood-brain barrier and deuterium, as the stable isotope, 
labeling is highly nontoxic, applications to animal models or even to humans could be possible. 
Moreover, future correlative imaging of SRS on Gln-d5 in live cells with recently demonstrated 
Cryo-ET investigation of down to angstrom-level resolution or together with quantitative 
proteomics can offer more comprehensive structural-function relationship for native mHtt-97Q 
aggregations.  
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Fig. 1. Experimental scheme for stimulated Raman scattering (SRS) microscopy with 
deuterated glutamine (Gln or Q) labeling. a) Plasmid construct of a model mutant Huntingtin 
(mHtt) Exon1 (ex1) protein linked with GFP at C terminus. b) Experimental setup of SRS 
Microscopy. c) Spontaneous Raman (blue dashed) and SRS (green) spectra of 60 mM Gln-d5 
solution. d) Linear dependence of SRS signals (at 2,147 cm-1) on Gln-d5 concentrations under a 
50-µs time constant. Error bar: SD. 
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Fig. 2. Live-cell SRS imaging of mHtt-97Q-GFP aggregates with Gln-d5 labeling. a) SRS 
imaging of mHtt aggregations (arrowheaded, at 2167 cm-1, C-D on), validated by fluorescence 
microscopy through GFP (green). Off-resonance image at 2035 cm-1 shows no signal. b) 
Comparison of SRS images for the same set of cells containing a medium-size mHtt-97Q-GFP 
aggregate (arrowheaded) at Gln-d5 (2167 cm
-1), CH3 (2940 cm
-1) and Amide I (1664 cm-1) 
channels. c) SRS imaging of an mHtt-97Q-GFP aggregate at 2134 cm-1 by Leucine-d10 (Leu-d10) 
labeling. d) Average mHtt Agg/cell ratios from SRS images of Gln-d5 labeling (5.75±1.03, 
n=13); amide (2.15±0.34, n=4); CH3 (1.66±0.14, n=10) and Leu-d10 labeling (2.45±0.33, n=10.) 
Error bar: SD. 
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Fig. 3. SRS imaging of mHtt-97Q protein aggregates without GFP. a) Plasmid construct of 
mHtt-97Q by chopping off GFP sequence from Fig. 1a. b) SRS images of aggregations with Gln-
d5 labeling at 2167 cm-1
 
(C-D on-resonance), 2035 cm-1 (C-D off-resonance), 2940 cm-1 (CH3) 
and 1664 cm-1 (Amide I). Scale bar: 10 μm. c) Agg/Cell ratios of mHtt-97Q in C-D (10.14±1.99, 
n=11) and CH3 (1.50±0.12, n=10) channels compared to that for mHtt-97Q-GFP (C-D: 
5.75±1.03, n=13; CH3: 1.66±0.14, n=10). d) SRS intensity ratios between CH3 and C-D channels 
(CH/CD ratio) on the same aggregates for mHtt-97Q (5.75±0.86, n=20) and mHtt-97Q-GFP 
(9.79±1.05, n=7). Error bar: SD. 
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Fig. 4. SRS quantifications of mHtt-97Q aggregates with different sizes. a) CH/CD ratios in 
Gln-d5 labeled aggregates decrease with the increase of aggregation sizes (The Pearson’s 
coefficient r=-0.559). b) Student t-test is significant when grouping the aggregates in (a) into 
small (< 10 µm2) and large (> 10 µm2) categories. ****p<0.0001. c-d) Minimum correlation 
between CH/CD ratios and aggregation sizes in Leu-d10 labeled aggregates, indicated by both the 
Pearson’s coefficient (r=-0.107) (c) and the Student t-test between small and large aggregation 
groups (d). e-f) Representative small (e, 6.7 µm2) and large (f, 19.1 µm2) Gln-d5 labeled mHtt-
97Q aggregates indicated with calculated mHtt-97Q protein concentrations. Scale bar: 10 μm. 
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Fig. 5. Hyperspectral SRS analysis for mHtt-97Q aggregates. a) Amide I SRS spectra of live 
aggregates (blue), live cell-background (red), fixed aggregates (green), and fixed cell-
background (magenta). b) Live-cell SRS C-D spectra of Gln-d5 labeled aggregates (green) and 
cell background (blue). c) SRS C-D spectra of Gln-d5 labeled aggregates (green) overlaid with 
that for Gln-d5 solids (purple) and solutions (red). d) Live-cell SRS CH3 spectra of aggregates 
(green), cell background (blue), and nucleoli (orange). Error bar: SD. 
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Fig. 6. Hyperspectral SRS study of interactions between mHtt aggregations and Heat 
Shock Proteins (HSPs). a) Fluorescence (green) and correlative SRS images for mHtt-97Q-GFP 
aggregates (white arrowheaded) at 2167 cm-1 (C-D on-resonance), 2035 cm-1 (off-resonance) and 
2940 cm-1 (CH3) in live cells after 100 nM Geldanamycin (GA) treatment for 20 h. Scale bar: 10 
μm. b) SRS spectra of normal mHtt aggregates (green) and a subset of GA treated small 
aggregates (red). c) SRS spectra of mHtt aggregates in fixed cells in DPBS buffer (green), 
MeOH (yellow) and DMSO (blue). Error bar: SD. 
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